Milanova Tsveta
Chief Commercial Officer
Milanova Tsveta has filed 4 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Apr 6, 2026.
On the most recent filing, Milanova Tsveta is listed as Chief Commercial Officer at AGIOS PHARMACEUTICALS, INC. Inside the rolling window, Milanova Tsveta reported no open-market purchases and 4 open-market sales totaling $353K in AGIO. The largest disclosed transaction in the window is a sale of 3,262 AGIO shares on Apr 2, 2026, worth $113K.
Companies traded
Other insiders at AGIO
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$353K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Milanova Tsveta made?
Milanova Tsveta has filed 4 SEC Form 4 filings (10 transaction rows) across 1 company since 2026.
Which companies does Milanova Tsveta trade?
Milanova Tsveta has filed SEC Form 4 disclosures for 1 company, including AGIO.
When was Milanova Tsveta's most recent SEC Form 4 filing?
Milanova Tsveta's most recent SEC Form 4 filing on Tracefour is dated Apr 6, 2026.
What is Milanova Tsveta's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Milanova Tsveta is listed as Chief Commercial Officer.
What is Milanova Tsveta's total buy and sell value in the current window?
Inside the rolling retention window, Milanova Tsveta bought $0 and sold $353K based on SEC Form 4 filings.
What was Milanova Tsveta's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,262 AGIO shares on 2026-04-02, worth $113K, per SEC Form 4 filings.